Eton Pharmaceuticals (ETON) Net Margin (2019 - 2026)
Eton Pharmaceuticals (ETON) posted Net Margin of 7.97% for Q4 2025, up 192.88% sequentially from 8.58% in Q3 2025, and up 1310.0% YoY from 0.57% in Q4 2024.
Eton Pharmaceuticals (ETON) Net Margin (2019 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Net Margin for 7 years, with the latest figure at 7.97% in Q4 2025.
- Quarterly Net Margin rose 1310.0% year-over-year to 7.97% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 5.49% (up 431.0% YoY) and the FY2025 annual result came in at 5.49%, up 431.0% from the prior year.
- Net Margin improved to 7.97% in Q4 2025 per ETON's latest filing, from 8.58% in the prior quarter.
- Over five years, Net Margin peaked at 43.0% in Q1 2021 and troughed at 786.32% in Q3 2021.
- A 5-year average of 59.44% and a median of 8.84% in 2025 frame the typical range for Net Margin.
- The widest YoY moves for Net Margin: up 2358427 bps in 2021, down 25621628 bps in 2021.
- Over 5 years, Net Margin stood at 17.05% in 2021, then surged by 94 bps to 33.02% in 2022, then plunged by 119 bps to 6.25% in 2023, then rose by 18 bps to 5.13% in 2024, then surged by 255 bps to 7.97% in 2025.
- According to Business Quant data, Net Margin over the past three periods registered 7.97%, 8.58%, and 13.66% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.65 Bn | 1.62 Bn | 25.41 Mn | 30.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.80% |
| Dec 31, 2025 | 7.97% |
| Sep 30, 2025 | -8.58% |
| Jun 30, 2025 | -13.66% |
| Mar 31, 2025 | -9.10% |
| Dec 31, 2024 | -5.13% |
| Sep 30, 2024 | 6.07% |
| Jun 30, 2024 | -33.51% |
| Mar 31, 2024 | -10.18% |
| Dec 31, 2023 | -6.25% |
| Sep 30, 2023 | -8.24% |
| Jun 30, 2023 | 38.00% |
| Mar 31, 2023 | -50.15% |
| Dec 31, 2022 | 33.02% |
| Sep 30, 2022 | -60.90% |
| Jun 30, 2022 | -31.16% |
| Mar 31, 2022 | -244.94% |
| Dec 31, 2021 | 17.05% |
| Sep 30, 2021 | -786.32% |
| Jun 30, 2021 | -65.73% |